Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation

BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. The cause of the motor symptoms is the loss of dopaminergic neurons in the substantia nigra with consequent depletion of dopamine in the striatum. Although the etiology of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Milena, Nissanka, Nadee, Peralta, Susana, Brambilla, Roberta, Diaz, Francisca, Moraes, Carlos T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818913/
https://www.ncbi.nlm.nih.gov/pubmed/27038906
http://dx.doi.org/10.1186/s13024-016-0090-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818913/
https://www.ncbi.nlm.nih.gov/pubmed/27038906
http://dx.doi.org/10.1186/s13024-016-0090-7

Ejemplares similares